Search research articles
Contact Us
Filters
Showing results (131-140 of 197) with videos related to
Page
of 20
Sort By:
Yeast (Chichester, England)
|
July 31, 2010
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses
Andreas Wadle, Axel Mischo, Sabine Strahl, et al.
The Journal of Clinical Investigation
|
June 24, 2006
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines
Hiroyoshi Nishikawa, Eiichi Sato, Gabriel Briones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2020
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
Shota Fukuoka, Hiroki Hara, Naoki Takahashi, et al.
Transplantation Direct
|
December 20, 2016
Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray
Keita Okubo, Hiroshi Wada, Atsushi Tanaka, et al.
Cancer Research Communications
|
December 16, 2024
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer
Shigehiro Koganemaru, Shohei Koyama, Fumitaka Suto, et al.
Cancer Immunology Research
|
February 25, 2018
Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
Kiyomi Shitaoka, Hiroshi Hamana, Hiroyuki Kishi, et al.
Cancer Immunology Research
|
May 25, 2016
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia
Hiroshi Ureshino, Takero Shindo, Hiroyoshi Nishikawa, et al.
BMC Cancer
|
April 22, 2020
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
Hideaki Bando, Daisuke Kotani, Takahiro Tsushima, et al.
Cancer Immunity
|
February 8, 2013
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy
Anurag Gupta, Natko Nuber, Christoph Esslinger, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 197) with videos related to
Sort By:
Page
of 20
Yeast (Chichester, England)
|
July 31, 2010
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses
Andreas Wadle, Axel Mischo, Sabine Strahl, et al.
The Journal of Clinical Investigation
|
June 24, 2006
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines
Hiroyoshi Nishikawa, Eiichi Sato, Gabriel Briones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2020
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
Shota Fukuoka, Hiroki Hara, Naoki Takahashi, et al.
Transplantation Direct
|
December 20, 2016
Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray
Keita Okubo, Hiroshi Wada, Atsushi Tanaka, et al.
Cancer Research Communications
|
December 16, 2024
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer
Shigehiro Koganemaru, Shohei Koyama, Fumitaka Suto, et al.
Cancer Immunology Research
|
February 25, 2018
Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
Kiyomi Shitaoka, Hiroshi Hamana, Hiroyuki Kishi, et al.
Cancer Immunology Research
|
May 25, 2016
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia
Hiroshi Ureshino, Takero Shindo, Hiroyoshi Nishikawa, et al.
BMC Cancer
|
April 22, 2020
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
Hideaki Bando, Daisuke Kotani, Takahiro Tsushima, et al.
Cancer Immunity
|
February 8, 2013
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy
Anurag Gupta, Natko Nuber, Christoph Esslinger, et al.
Page
of 20